Health Statistics : Lupus

• Publication date: March 2011

In 2010, Datamonitor estimates that there were about 404,300 prevalent cases of systemic lupus erythematosus (SLE) in the seven major industries, with approximately 80-90% of these cases in women between 45 and 64 years of age. The number of prevalent cases is expected to increase to approximately 420,000 cases by 2020.Gain insight to sector opportunity, includin...

In 2010, Datamonitor estimates that there were about 404,300 prevalent cases of systemic lupus erythematosus (SLE) in the seven major industries, with approximately 80-90% of these cases in women between 45 and 64 years of age. The number of prevalent cases is expected to increase to approximately 420,000 cases by 2020.Gain insight to sector opportunity, including a robust 10-year prevalence projection of prevalent systemic lupus erythematosus cases.Understand the key epidemiologic risk factors associated with systemic lupus erythematosus.Between 2010 and 2020, Datamonitor expects to see an overall increase in the number of prevalent cases of systemic lupus erythematosus in the US, France, Spain, and the UK. The largest increase is expected in the US. This is due to the fact that the population in women aged 45-64 is increasing in these countries.A decrease in prevalent cases of systemic lupus erythematosus is expected in Japan, Germany, and Italy. The largest decrease is expected in Japan. This is due to the fact that the population in women aged 45-64 is decreasing in these countries, along with the population on the whole.Women aged between 45 and 64 are expected to constitute approximately 80-90% of cases of systemic lupus erythematosus.What are the most robust sources for systemic lupus erythematosus prevalence?How will the patient population change of the next decade in the US, Japan, and the five major EU industry s (France, Germany, Italy, Spain, and the UK)?How do changes in population structure and risk factors affect the trend in prevalent systemic lupus erythematosus cases?

Global Pathology Industry

Summary
Risk factors
Epidemiologic projection
OVERVIEW
Catalyst
Summary
DISEASE DEFINITION AND DIAGNOSIS CRITERIA
Diagnosis criteria
MANIFESTATION OF DISEASE
Arthritis
Cutaneous symptoms
Lupus nephritis
Central nervous system
Vasculitis
GLOBAL VARIATION AND HISTORICAL TRENDS
Morbidity and mortality
Incidence
Prevalence
RISK FACTORS
Race and ethnicity
Gender
Age
Genetics
Environment
CO-MORBIDITIES
Cardiovascular diseases
Bacterial infections
EPIDEMIOLOGIC FORECASTING
Sources of epidemiologic data
Description of methods
US
Japan
France
Germany
Italy
Spain
UK
EPIDEMIOLOGIC RESULTS
Current prevalent cases and future trends
Annual growth rate of disease population
DISCUSSION
Strengths and limitations of Datamonitor’s epidemiologic projections
BIBLIOGRAPHY
Journal papers
Websites
Datamonitor reports
APPENDIX
Module methodology

Autoimmune Disease in World

Fiji Schizophrenia, Total, Male, Dalys

• $ 250
• Industry data
• May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

• Industries : Pathology
• Countries : Fiji, World

Niue Schizophrenia, Total, Male, Dalys

• $ 250
• Industry data
• May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

• Industries : Pathology
• Countries : World

Congo-brazzaville Schizophrenia, Dalys

• $ 250
• Industry data
• May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

• Industries : Pathology
• Countries : World

Oman Schizophrenia, Total, Male, Dalys

• $ 250
• Industry data
• May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

• Industries : Pathology
• Countries : Oman, World

Mali Schizophrenia, Total, Male, Dalys

• $ 250
• Industry data
• May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

• Industries : Pathology
• Countries : Mali, World

Pathology in World

Palau Post-traumatic Stress Disorder, 45-59 Yrs, Male, Dalys

• $ 250
• Industry data
• May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

• Industries : Pathology
• Countries : World

Iraq Prostate Cancer, 45-59 Yrs, Male, Dalys

• $ 250
• Industry data
• May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

• Industries : Pathology
• Countries : Iraq, World

Cote D`ivoire Post-traumatic Stress Disorder, 45-59 Yrs, Male, Dalys

• $ 250
• Industry data
• May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

• Industries : Pathology
• Countries : World

Congo-brazzaville Peptic Ulcer Disease, 45-59 Yrs, Male, Dalys

• $ 250
• Industry data
• May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

• Industries : Pathology
• Countries : World

Mali Post-traumatic Stress Disorder, 45-59 Yrs, Male, Dalys

• $ 250
• Industry data
• May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

• Industries : Pathology
• Countries : Mali, World